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ABSTRACT 
Serum prolactin level was measured in 20 male and 11 female drug naive patients of 
schizophrenia Subsequently, these patients were treated with antipsychotics and ECTs. The severity 
of psychopathology at the baseline rind subsquent improvement at the end of 3 weeks and 6 weeks 
was assessed on modifies brief •.'•sychiatric rating scale (BPRS). 
Contrary to the expectations, a two fold increase in serum prolactin level was observed in drug 
naive male and female patients of schizophrenia The difference was found to be statictically significant 
in males No correlation was observed between the baseline serum prolactin level and the severity of 
baseline psychopathology and subsequent improvement in psychopathology at the end of 3 weeks 
and 6 weeks From the present study it seems that baseline serum prolactine level in drug naive 
patients of schizophrenia may not be a reliable indicator of psychopathology and prognosis. 
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Prolactin is an anterior pituitary hormone. 
The release of prolactin from the anterior pituitary 
is regulated by prolactin inhibitory factor (PIF), 
which is the neurotransmitter dopamine. 
Increased dopaminergic activity in the 
mesolimbic dopaminergic projections has been 
postulated in schizophrenia (Kaplan et al 1994). 
Elevated serum prolactin levels have been 
considered virtually unavoidable in most patients 
treated with therapeutic doses of conventional 
antipsychotics which block the dopamine 
receptors (Hamner & Arana. 1998). It is likely that 
serum prolactin level which gives us the idea 
about the dopaminergic activity at the 
infundibulo-pituitary axis, may also reflect the 
mesolimbic dopaminergic activity On the basis 
of this hypothesis it may be postulated that in 
drug naive patients of schizophrenia, due to 
increase in dopaminergic activity, there may be 
decrease m serum prolactin level and there may 
be a negative correlation between severity of 
psychopathology and serum prolactin level i.e 
higher the dopamine levels, higher the 
psychopathology and lower the serum prolactin 
level. Various studies (Chatterjee.1988; 
Klemman et al.,1982; Kuruvilla et al.,1986; 
Meltzer et al.,1974) have reported normal or 
lower serum prolactin levels in drug naive 
patients of acute schizophrenia or decreased 
prolactin level in patients of chronic 
schizophrenia without ventricular dilatation. 
Some of studies have predicted association 
between early relapse following neuroleptic 
withdrawal and low serum prolactin levels (Brown 
& Laughren,1981; Libermanetal.,1990). If some 
correlation can be established between the 
baseline serum prolactin levels and severity of 
psycnopathology in drug naive patients of 
schizophrenia, the serum prolactin level can be 
used as an objective parameter for monitoring 
the improvement and course in schizophrenia. 
In order to test this postulate, the present 
study was undertaken with the following aims : 
i) to study the serum prolactin level (baseline) in 
the drug naive patients of schizophrenia; ii) to 
study the correlation between the baseline serum 
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prolactin level and severity of psychopathology 
at the baseline and iii) to study the correlation 
between baseline serum prolactin and 
improvement in psychopathology after treatment 
with antipsychotics and ECTs at the end of 3 
weeks and 6 weeks. 
MATERIAL AND METHOD 
Site : The study was conducted in a non-
governmental psychiatric treatment center -
Silver Mind Hospital, Mumbai. 
Sample : 31 consecutive patients (20 males and 
11 females) who were attending the outpatient 
department of the hospital and who satisfied the 
inclusion and exclusion criteria were included in 
the study. 
Inclusion criteria : i) satisfying 1CD-10 criteria 
(WHO, 1992) for schizophrenia; ii) first episode; 
iii) drug naive patients (who have never received 
any antipsychotic in the past) and iv) consent & 
willingness to participate in the study and maintain 
follow up for a period of at least six weeks. 
Exclusion criteria : i) presence of any other 
psychiatric morbidity, like alcohol dependence 
which is likely to inerfere with diagnosis and 
follow up; ii) presence of any concurrent medical 
or endocrine disorder; iii) pregnant or lactating 
women; iv) history of delivery in last 1 year and 
v) patients on any other medications which are 
likely to alter the prolactin levels. 
All the patients were clinically examined, 
individually interviewed and diagnosed by a 
consultant psychiatrist and required data was 
collected as per the specially prepared proforma 
for the study. Objective data was obtained from 
one of the close relative accompanying the patient. 
In order to assess the severity of 
psychopathology, all the patients were rated on 
Brief Psychiatric Rating Scale (BPRS) (Overall 
& Graham, 1962) at the baseline and at the end 
of 3rd and 6th weeks. 
5 ml of plain venous blood was collected 
before giving any medication for serum prolactin 
level which was estimated by radio-immuno 
assay (RIA) technique. Control values given with 
the RIA-kit for males and females were 
confirmed by running 31 blood samples (20 
males, 11 females) from healthy normal 
volunteers after obtaining their informed consent. 
All the patients were treated with 
haloperidol 15-45 mg/day, trihexyphenedyl 6-12 
mg/day and a course of 8 modified ECTs on 
alternate day basis. 
As mentioned earlier the improvement 
was assessed on BPRS at the end of 3 weeks 
and 6 weeks. 
The baseline serum prolactin in drug naive 
male and female patients of schizophrenia was 
compared with that of controls using student's 
t-test. Correlation coefficient between the 
baseline serum prolactin level and scores on 
BPRS at the baseline, 3 weeks and 6 weeks in 
male and female patients was obtained. 
RESULTS 
The sample consisted of 20 males and 11 
females. Out of these 1 male patient and 3 female 
patients were dropped out of analysis as there 
serum prolactin levels were very high (more than 
100 ng/ml). This may be due to accidental 
exposure to neuroleptic drugs. So 19 male 
patients and 8 female patients were included in 
the final analysis. The mean (SD) age of the male 
patients (n=19) was 23.2 (4.8) years and female 
(n=8) population was 22.3 (5.6) years. 
The control group also consisted of 20 
male and 11 female volunteers. The mean (SD) 
age of male volunteers was 22.6 (3.8) years and 
female volunteers was 21.3 (4.5) years. 
The study group and the volunteers were 
comparable on age (males : t=0.83. d f =37, 
N.S.; females : t=021. d.f.=17, N.S.). 
The mean (SD) baseline serum prolactin 
level in drug naive patients of schizophrenic 
males (n=19) was found to be 28.37 (11.26) ng/ 
ml and in females (n=8) was 48.31 (24.46) ng/ 
ml. These values were two folds higher than the 
values in control males (n=20) 12.20 (5.05) ng/ 
ml and females (n=11) 23.72 (7.98) ng/ml (for 
males t=2.30, d.f.37, p<0.05; for females t=0.33, 
d.f.=17, D>0.05). The difference was staistically 
significant in males but it was not found to be 
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TABLE 1 
CORRELATION COEFFICIENT BETWEEN SERUM 
PROLACTIN AND BPRS (MALES) 
Baseline 
At 3 weeks 
At 6 weeks 
Value of 
r(n=19) 
0 195 
0223 
0 098 
Sigr 
t 
081 
0,94 
0.098 
ificant 
d.f 
17 
17 
17 
P 
N.S. 
N.S. 
N.S. 
TABLE 2 
CORRELATION COEFFICIENT BETWEEN SERUM 
PROLACTIN AND BPRS (FEMALES) 
Basekne 
At 3 weeks 
At 6 weeks 
Value of 
r (n=8) 
0 071 
0.46 
0.50 
Significant 
t 
0.17 
1 26 
1.41 
d.f. 
6 
6 
6 
P 
N.S 
N.S. 
N.S. 
significant in females probably due to a relatively 
small sarnple size. 
Table 1 & 2 shows the correlation 
coefficient between serum prolactin and BPRS 
scores at baseline, at the end of 3 weeks and 6 
weeks in males and females respectively. It was 
noted that there was no significant correlation 
between the baseline serum prolactin level and 
scores on BPRS at the baseline and at the end 
of 3 weeks and 6 weeks in males as well as in 
females 
DISCUSSION 
Serum prolactin has been studied in a 
variety of psychiatnc disorder like schizophrenia, 
mania (Cookson et al .1982) and depression 
(Lmkowski et al .1986; Maeda et al ,1975). As 
mentioned earlier some of the studies have 
reported normal or reduced serum prolactin level 
in drug naive patients of schizophrenia 
<Chatterjee 1988: Klemman et al 1982; Kuruvilla 
et al ,1986 Meltzer et al .1974) In contrast to 
these studies and contrary to the hypothesis of 
the present study a significantly higher baseline 
serum prolactin ieve! was observed ir; males as 
weil as m females Elevated serum prolactin 
levels have been reported after stress, 
hypoglycemia, & neuroleptics (Hamner & Arana, 
1998. Maeda et al 1975, Sacher et al.,1973). 
As mentioned earlier, a lower serum prolactin 
was expected in drug naive patients of 
schizophrenia due to increased activity of 
dopaminergic system but instead a significantly 
higher level was noticed in these patients. The 
increase was statistically significant in males. In 
female patients, though the level were higher, it 
was not found to be statistically significant 
probably due to high standard deviation and 
small sample size. The increased p/olactin level 
in drug naive patients of schizophrenia was 
unexpected, intriguing and difficult to explain. 
There was no correlation between the 
serum prolactin level and score on BPRS at the 
baseline, at the end of 3 weeks and 6 weeks. 
It seems that serum prolactin level depends 
on number of factors such as sax of the patient, 
physical and psychological stress, hypoglycemia 
etc., apart from presence or absence of psychiatric 
disorder and use of psychotropic drugs. It has also 
been proposed that prolactin secretion pattern is 
different in acute state (Roncoroni,1989) and 
marginal or significant increase in the level of 
prolactin may be expected primarily due to 
'nondopaminergic excitatory factors' of prolactin 
secretion (Victor, 1985). 
This suggests that serum prolactin level 
can not be reliably used as an objective indicator 
of psychopathology in patient of schizophrenia 
as postulated in the study. 
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